User profiles for Jonah B Sacha

Jonah Sacha

Oregon Health & Science University
Verified email at ohsu.edu
Cited by 6430

Immune clearance of highly pathogenic SIV infection

…, MK Axthelm, JA Nelson, K Früh, JB Sacha… - Nature, 2013 - nature.com
Established infections with the human and simian immunodeficiency viruses (HIV and SIV,
respectively) are thought to be permanent with even the most effective immune responses …

[PDF][PDF] Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control

…, RP Joshi, KA Weeks, JE Rood, AM Berkley, JB Sacha… - Immunity, 2008 - cell.com
Virus-specific CD8 + T cells probably mediate control over HIV replication in rare individuals,
termed long-term nonprogressors (LTNPs) or elite controllers. Despite extensive …

Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms

SG Hansen, JB Sacha, CM Hughes, JC Ford… - Science, 2013 - science.org
Introduction CD8 + T cell responses focus on a small fraction of total pathogen-encoded
peptides, which are similar among individuals with shared major histocompatibility complex (…

[HTML][HTML] TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection

…, M Maurer, AJ Korman, SG Deeks, JB Sacha… - PLoS …, 2016 - journals.plos.org
HIV infection induces phenotypic and functional changes to CD8 + T cells defined by the
coordinated upregulation of a series of negative checkpoint receptors that eventually result in T …

Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E

…, BT Korber, AJ McMichael, S Gnanakaran, JB Sacha… - Science, 2016 - science.org
Major histocompatibility complex E (MHC-E) is a highly conserved, ubiquitously expressed,
nonclassical MHC class Ib molecule with limited polymorphism that is primarily involved in …

Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression

JB Sacha, C Chung, EG Rakasz… - The Journal of …, 2007 - journals.aai.org
CD8+ T cells are a key focus of vaccine development efforts for HIV. However, there is no
clear consensus as to which of the nine HIV proteins should be used for vaccination. The early …

Comparison of the superagonist complex, ALT-803, to IL15 as cancer immunotherapeutics in animal models

…, AC Edwards, K Han, S Shi, S Alter, JB Sacha… - Cancer immunology …, 2016 - AACR
IL15, a potent stimulant of CD8 + T cells and natural killer (NK) cells, is a promising cancer
immunotherapeutic. ALT-803 is a complex of an IL15 superagonist mutant and a dimeric IL15 …

[HTML][HTML] CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14

…, PA Mudd, E Akalin, LC Ndhlovu, JB Sacha - International Journal of …, 2021 - Elsevier
Objective Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
now a global pandemic. Emerging results indicate a dysregulated immune response. Given …

Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques

…, VM Hirsch, BS Graham, JR Mascola, JB Sacha… - Nature medicine, 2016 - nature.com
Prevention of mother-to-child transmission (MTCT) of HIV remains a major objective where
antenatal care is not readily accessible. We tested HIV-1–specific human neutralizing …

Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19

…, TJ Henrich, SG Deeks, JB Sacha… - Journal of leukocyte …, 2021 - academic.oup.com
The global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is a highly pathogenic RNA virus causing coronavirus disease 2019 (COVID-19) in …